1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Betz, S.F.
Schnuchel, A.
Wang, H.
Olejniczak, E.T.
Meadows, R.P.
Fesik, S.W.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Proc.Natl.Acad.Sci.USA
PNASA6
0040
0027-8424
95
7909
7914
10.1073/pnas.95.14.7909
9653114
Solution structure of the cytohesin-1 (B2-1) Sec7 domain and its interaction with the GTPase ADP ribosylation factor 1.
1998
10.2210/pdb1bc9/pdb
pdb_00001bc9
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
23388.758
CYTOHESIN-1
SEC7 DOMAIN,
1
man
polymer
B2-1, SEC7 HOMOLOG B2-1
no
no
MKNMQRNKQVAMGRKKFNMDPKKGIQFLIENDLLKNTCEDIAQFLYKGEGLNKTAIGDYLGERDEFNIQVLHAFVELHEF
TDLNLVQALRQFLWSFRLPGEAQKIDRMMEAFAQRYCQCNNGVFQSTDTCYVLSFAIIMLNTSLHNPNVKDKPTVERFIA
MNRGINDGGDLPEELLRNLYESIKNEPFKIPELEHHHHHH
MKNMQRNKQVAMGRKKFNMDPKKGIQFLIENDLLKNTCEDIAQFLYKGEGLNKTAIGDYLGERDEFNIQVLHAFVELHEF
TDLNLVQALRQFLWSFRLPGEAQKIDRMMEAFAQRYCQCNNGVFQSTDTCYVLSFAIIMLNTSLHNPNVKDKPTVERFIA
MNRGINDGGDLPEELLRNLYESIKNEPFKIPELEHHHHHH
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
Escherichia
Escherichia coli
sample
BL21
B2-1
9606
SPLEEN
Homo sapiens
B2-1
469008
Escherichia coli BL21(DE3)
BL21 (DE3)
PLASMID
PET-20B
database_2
pdbx_database_status
pdbx_struct_assembly
pdbx_struct_oper_list
struct_ref_seq_dif
repository
Initial release
Version format compliance
Version format compliance
Database references
Derived calculations
Other
1
0
1999-05-11
1
1
2008-03-24
1
2
2011-07-13
1
3
2022-02-16
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.process_site
_struct_ref_seq_dif.details
Y
BNL
1998-05-06
REL
THE STRUCTURE WAS DETERMINED USING TRIPLE-RESONANCE NMR SPECTROSCOPY ON 13C, 15N-LABELED CYTOHESIN-1 SEC7 DOMAIN.
MINIMIZED AVERAGE
287
1
HNCA
HN(CO)CA
HN(CA)CB
HN (COCA)CB
HNCO
HN(CA)CO
HCCH-TOCSY
13C-NOESY
15N-NOESY
HNHA-J
0.47 M
6.8
1
atm
305
K
REFINEMENT DETAILS CAN BE FOUND IN THE JRNL CITATION.
DISTANCE GEOMETRY/ SIMULATED ANNEALING
20 MM NAPI, 150 MM (NH4)2SO4, 3MM DTT, 10% D2O
BRUNGER
refinement
X-PLOR
3.1
structure solution
X-PLOR
3.1
500
Bruker
DRX500
600
Bruker
DRX600
750
Bruker
AMX750
800
Bruker
DRX800
MET
57
n
1
MET
57
A
LYS
58
n
2
LYS
58
A
ASN
59
n
3
ASN
59
A
MET
60
n
4
MET
60
A
GLN
61
n
5
GLN
61
A
ARG
62
n
6
ARG
62
A
ASN
63
n
7
ASN
63
A
LYS
64
n
8
LYS
64
A
GLN
65
n
9
GLN
65
A
VAL
66
n
10
VAL
66
A
ALA
67
n
11
ALA
67
A
MET
68
n
12
MET
68
A
GLY
69
n
13
GLY
69
A
ARG
70
n
14
ARG
70
A
LYS
71
n
15
LYS
71
A
LYS
72
n
16
LYS
72
A
PHE
73
n
17
PHE
73
A
ASN
74
n
18
ASN
74
A
MET
75
n
19
MET
75
A
ASP
76
n
20
ASP
76
A
PRO
77
n
21
PRO
77
A
LYS
78
n
22
LYS
78
A
LYS
79
n
23
LYS
79
A
GLY
80
n
24
GLY
80
A
ILE
81
n
25
ILE
81
A
GLN
82
n
26
GLN
82
A
PHE
83
n
27
PHE
83
A
LEU
84
n
28
LEU
84
A
ILE
85
n
29
ILE
85
A
GLU
86
n
30
GLU
86
A
ASN
87
n
31
ASN
87
A
ASP
88
n
32
ASP
88
A
LEU
89
n
33
LEU
89
A
LEU
90
n
34
LEU
90
A
LYS
91
n
35
LYS
91
A
ASN
92
n
36
ASN
92
A
THR
93
n
37
THR
93
A
CYS
94
n
38
CYS
94
A
GLU
95
n
39
GLU
95
A
ASP
96
n
40
ASP
96
A
ILE
97
n
41
ILE
97
A
ALA
98
n
42
ALA
98
A
GLN
99
n
43
GLN
99
A
PHE
100
n
44
PHE
100
A
LEU
101
n
45
LEU
101
A
TYR
102
n
46
TYR
102
A
LYS
103
n
47
LYS
103
A
GLY
104
n
48
GLY
104
A
GLU
105
n
49
GLU
105
A
GLY
106
n
50
GLY
106
A
LEU
107
n
51
LEU
107
A
ASN
108
n
52
ASN
108
A
LYS
109
n
53
LYS
109
A
THR
110
n
54
THR
110
A
ALA
111
n
55
ALA
111
A
ILE
112
n
56
ILE
112
A
GLY
113
n
57
GLY
113
A
ASP
114
n
58
ASP
114
A
TYR
115
n
59
TYR
115
A
LEU
116
n
60
LEU
116
A
GLY
117
n
61
GLY
117
A
GLU
118
n
62
GLU
118
A
ARG
119
n
63
ARG
119
A
ASP
120
n
64
ASP
120
A
GLU
121
n
65
GLU
121
A
PHE
122
n
66
PHE
122
A
ASN
123
n
67
ASN
123
A
ILE
124
n
68
ILE
124
A
GLN
125
n
69
GLN
125
A
VAL
126
n
70
VAL
126
A
LEU
127
n
71
LEU
127
A
HIS
128
n
72
HIS
128
A
ALA
129
n
73
ALA
129
A
PHE
130
n
74
PHE
130
A
VAL
131
n
75
VAL
131
A
GLU
132
n
76
GLU
132
A
LEU
133
n
77
LEU
133
A
HIS
134
n
78
HIS
134
A
GLU
135
n
79
GLU
135
A
PHE
136
n
80
PHE
136
A
THR
137
n
81
THR
137
A
ASP
138
n
82
ASP
138
A
LEU
139
n
83
LEU
139
A
ASN
140
n
84
ASN
140
A
LEU
141
n
85
LEU
141
A
VAL
142
n
86
VAL
142
A
GLN
143
n
87
GLN
143
A
ALA
144
n
88
ALA
144
A
LEU
145
n
89
LEU
145
A
ARG
146
n
90
ARG
146
A
GLN
147
n
91
GLN
147
A
PHE
148
n
92
PHE
148
A
LEU
149
n
93
LEU
149
A
TRP
150
n
94
TRP
150
A
SER
151
n
95
SER
151
A
PHE
152
n
96
PHE
152
A
ARG
153
n
97
ARG
153
A
LEU
154
n
98
LEU
154
A
PRO
155
n
99
PRO
155
A
GLY
156
n
100
GLY
156
A
GLU
157
n
101
GLU
157
A
ALA
158
n
102
ALA
158
A
GLN
159
n
103
GLN
159
A
LYS
160
n
104
LYS
160
A
ILE
161
n
105
ILE
161
A
ASP
162
n
106
ASP
162
A
ARG
163
n
107
ARG
163
A
MET
164
n
108
MET
164
A
MET
165
n
109
MET
165
A
GLU
166
n
110
GLU
166
A
ALA
167
n
111
ALA
167
A
PHE
168
n
112
PHE
168
A
ALA
169
n
113
ALA
169
A
GLN
170
n
114
GLN
170
A
ARG
171
n
115
ARG
171
A
TYR
172
n
116
TYR
172
A
CYS
173
n
117
CYS
173
A
GLN
174
n
118
GLN
174
A
CYS
175
n
119
CYS
175
A
ASN
176
n
120
ASN
176
A
ASN
177
n
121
ASN
177
A
GLY
178
n
122
GLY
178
A
VAL
179
n
123
VAL
179
A
PHE
180
n
124
PHE
180
A
GLN
181
n
125
GLN
181
A
SER
182
n
126
SER
182
A
THR
183
n
127
THR
183
A
ASP
184
n
128
ASP
184
A
THR
185
n
129
THR
185
A
CYS
186
n
130
CYS
186
A
TYR
187
n
131
TYR
187
A
VAL
188
n
132
VAL
188
A
LEU
189
n
133
LEU
189
A
SER
190
n
134
SER
190
A
PHE
191
n
135
PHE
191
A
ALA
192
n
136
ALA
192
A
ILE
193
n
137
ILE
193
A
ILE
194
n
138
ILE
194
A
MET
195
n
139
MET
195
A
LEU
196
n
140
LEU
196
A
ASN
197
n
141
ASN
197
A
THR
198
n
142
THR
198
A
SER
199
n
143
SER
199
A
LEU
200
n
144
LEU
200
A
HIS
201
n
145
HIS
201
A
ASN
202
n
146
ASN
202
A
PRO
203
n
147
PRO
203
A
ASN
204
n
148
ASN
204
A
VAL
205
n
149
VAL
205
A
LYS
206
n
150
LYS
206
A
ASP
207
n
151
ASP
207
A
LYS
208
n
152
LYS
208
A
PRO
209
n
153
PRO
209
A
THR
210
n
154
THR
210
A
VAL
211
n
155
VAL
211
A
GLU
212
n
156
GLU
212
A
ARG
213
n
157
ARG
213
A
PHE
214
n
158
PHE
214
A
ILE
215
n
159
ILE
215
A
ALA
216
n
160
ALA
216
A
MET
217
n
161
MET
217
A
ASN
218
n
162
ASN
218
A
ARG
219
n
163
ARG
219
A
GLY
220
n
164
GLY
220
A
ILE
221
n
165
ILE
221
A
ASN
222
n
166
ASN
222
A
ASP
223
n
167
ASP
223
A
GLY
224
n
168
GLY
224
A
GLY
225
n
169
GLY
225
A
ASP
226
n
170
ASP
226
A
LEU
227
n
171
LEU
227
A
PRO
228
n
172
PRO
228
A
GLU
229
n
173
GLU
229
A
GLU
230
n
174
GLU
230
A
LEU
231
n
175
LEU
231
A
LEU
232
n
176
LEU
232
A
ARG
233
n
177
ARG
233
A
ASN
234
n
178
ASN
234
A
LEU
235
n
179
LEU
235
A
TYR
236
n
180
TYR
236
A
GLU
237
n
181
GLU
237
A
SER
238
n
182
SER
238
A
ILE
239
n
183
ILE
239
A
LYS
240
n
184
LYS
240
A
ASN
241
n
185
ASN
241
A
GLU
242
n
186
GLU
242
A
PRO
243
n
187
PRO
243
A
PHE
244
n
188
PHE
244
A
LYS
245
n
189
LYS
245
A
ILE
246
n
190
ILE
246
A
PRO
247
n
191
PRO
247
A
GLU
248
n
192
GLU
248
A
LEU
249
n
193
LEU
249
A
GLU
250
n
194
GLU
250
A
HIS
251
n
195
HIS
251
A
HIS
252
n
196
HIS
252
A
HIS
253
n
197
HIS
253
A
HIS
254
n
198
HIS
254
A
HIS
255
n
199
HIS
255
A
HIS
256
n
200
HIS
256
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
1
A
A
O
HG1
ILE
THR
194
198
1.54
1
A
LYS
58
-48.69
97.15
1
A
ASP
76
-170.27
140.77
1
A
LYS
78
79.46
-4.13
1
A
ASN
92
-71.66
-165.35
1
A
GLU
95
-74.23
-74.69
1
A
PHE
100
-105.42
-71.64
1
A
LYS
103
-144.73
-68.35
1
A
GLU
105
-108.95
50.41
1
A
GLU
118
-140.97
-81.59
1
A
ARG
119
177.79
-71.28
1
A
ASP
120
45.44
-166.58
1
A
VAL
131
-114.39
57.52
1
A
GLU
132
-154.52
28.54
1
A
GLU
135
42.66
73.26
1
A
PHE
136
-163.16
28.55
1
A
LEU
139
-88.71
-75.13
1
A
ASN
140
155.99
157.35
1
A
PHE
148
-161.21
26.37
1
A
PHE
152
-175.88
-37.70
1
A
ARG
153
74.49
127.53
1
A
GLU
157
72.85
-165.37
1
A
ALA
158
-47.63
106.35
1
A
GLN
159
-178.33
-41.94
1
A
ASN
176
-128.11
-68.69
1
A
ASN
177
71.76
82.46
1
A
PHE
180
-96.42
41.83
1
A
GLN
181
73.16
-72.62
1
A
SER
182
-150.32
-78.22
1
A
THR
183
-152.87
-45.76
1
A
THR
198
-49.13
-71.03
1
A
HIS
201
-115.20
78.79
1
A
LYS
206
-48.99
99.59
1
A
ASP
207
-136.17
-56.02
1
A
LYS
208
71.58
64.45
1
A
ASP
226
76.93
-58.77
1
A
LEU
227
63.27
122.03
1
A
PRO
243
-55.01
-154.40
1
A
PHE
244
70.01
152.71
1
A
LYS
245
-172.69
-137.54
1
A
ILE
246
-36.23
155.47
1
A
PRO
247
-47.63
176.05
1
A
HIS
252
52.59
71.43
1
A
HIS
255
-44.41
98.43
model building
X-PLOR
3.1
refinement
X-PLOR
3.1
phasing
X-PLOR
3.1
CYTOHESIN-1/B2-1 SEC7 DOMAIN, NMR, MINIMIZED AVERAGE STRUCTURE
1
Y
N
A
GLN
61
A
GLN
5
HELX_P
A
MET
75
A
MET
19
1
1
15
A
LYS
78
A
LYS
22
HELX_P
A
GLU
86
A
GLU
30
1
2
9
A
CYS
94
A
CYS
38
HELX_P
A
TYR
102
A
TYR
46
1
3
9
A
LYS
109
A
LYS
53
HELX_P
A
TYR
115
A
TYR
59
1
4
7
A
GLU
121
A
GLU
65
HELX_P
A
ALA
129
A
ALA
73
1
5
9
A
LEU
141
A
LEU
85
HELX_P
A
ARG
146
A
ARG
90
1
6
6
A
LYS
160
A
LYS
104
HELX_P
A
TYR
172
A
TYR
116
1
7
13
A
ASP
184
A
ASP
128
HELX_P
A
LEU
200
A
LEU
144
1
8
17
A
VAL
211
A
VAL
155
HELX_P
A
ILE
221
A
ILE
165
1
9
11
A
GLU
229
A
GLU
173
HELX_P
A
ASN
241
A
ASN
185
1
10
13
EXCHANGE FACTOR
EXCHANGE FACTOR, INTEGRIN BINDING PROTEIN
CYH1_HUMAN
UNP
1
1
Q15438
MEEDDSYVPSDLTAEERQELENIRRRKQELLADIQRLKDEIAEVANEIENLGSTEERKNMQRNKQVAMGRKKFNMDPKKG
IQFLIENDLLKNTCEDIAQFLYKGEGLNKTAIGDYLGERDEFNIQVLHAFVELHEFTDLNLVQALRQFLWSFRLPGEAQK
IDRMMEAFAQRYCQCNNGVFQSTDTCYVLSFAIIMLNTSLHNPNVKDKPTVERFIAMNRGINDGGDLPEELLRNLYESIK
NEPFKIPEDDGNDLTHTFFNPDREGWLLKLGGGRVKTWKRRWFILTDNCLYYFEYTTDKEPRGIIPLENLSIREVEDSKK
PNCFELYIPDNKDQVIKACKTEADGRVVEGNHTVYRISAPTPEEKEEWIKCIKAAISRDPFYEMLAARKKKVSSTKRH
58
256
1BC9
58
256
Q15438
A
1
2
200
1
ASP
conflict
LEU
249
1BC9
A
Q15438
UNP
249
193
1
ASP
conflict
GLU
250
1BC9
A
Q15438
UNP
250
194
1
GLY
conflict
HIS
251
1BC9
A
Q15438
UNP
251
195
1
ASN
conflict
HIS
252
1BC9
A
Q15438
UNP
252
196
1
ASP
conflict
HIS
253
1BC9
A
Q15438
UNP
253
197
1
LEU
conflict
HIS
254
1BC9
A
Q15438
UNP
254
198
1
THR
conflict
HIS
255
1BC9
A
Q15438
UNP
255
199
1
P 1